摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-1-(3-甲氧基-4-亚硝基苯基)-2-苯基重氮基烯 | 26944-26-3

中文名称
(E)-1-(3-甲氧基-4-亚硝基苯基)-2-苯基重氮基烯
中文别名
N-溴乙酰基葡萄糖胺
英文名称
N-Bromoacetylglucosamine
英文别名
2-bromo-N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide
(E)-1-(3-甲氧基-4-亚硝基苯基)-2-苯基重氮基烯化学式
CAS
26944-26-3
化学式
C8H14BrNO6
mdl
——
分子量
300.1
InChiKey
OFCLIDPLXVQJAP-LRSZDJBLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.6
  • 重原子数:
    16
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    127
  • 氢给体数:
    5
  • 氢受体数:
    6

文献信息

  • Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides
    申请人:The Regents of the University of California
    公开号:US11234992B2
    公开(公告)日:2022-02-01
    The disclosure provides for therapies and methods to treat atherosclerosis and/or hyperlipidemia, and complications resulting therefrom, with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
    本公开提供了治疗动脉粥样硬化和/或高脂血症及其并发症的疗法和方法,其组合物包含治疗有效量的一种或多种人乳低聚糖。
  • METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES
    申请人:THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    公开号:EP1212056B1
    公开(公告)日:2005-12-07
  • INHIBITORS OF POLYSIALIC ACID DE-N-ACETYLASE AND METHODS FOR USING THE SAME
    申请人:Children's Hospital & Research Center at Oakland
    公开号:EP2173166A1
    公开(公告)日:2010-04-14
  • DISIALYLLACTO-N-TETRAOSE (DSLNT) OR VARIANTS, ISOMERS, ANALOGS AND DERIVATIVES THEREOF TO PREVENT OR INHIBIT BOWEL DISEASE
    申请人:The Regents of The University of California
    公开号:EP2670399A2
    公开(公告)日:2013-12-11
  • METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES
    申请人:The Regents of the University of California
    公开号:US20190269713A1
    公开(公告)日:2019-09-05
    The disclosure provides for therapies and methods to treat atherosclerosis and/or hyperlipidemia, and complications resulting therefrom, with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
查看更多